# Evaluation of the Efficacy and Safety of DBL-4pen Mobile Application in Patients With Type 2 Diabetes

> **NCT05733962** · NA · UNKNOWN · sponsor: **Diabeloop** · enrollment: 40 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DEVICE:** Use of the device DBL-4pen

## Key facts

- **NCT ID:** NCT05733962
- **Lead sponsor:** Diabeloop
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-01
- **Primary completion:** 2024-12
- **Final completion:** 2025-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-09-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05733962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05733962, "Evaluation of the Efficacy and Safety of DBL-4pen Mobile Application in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05733962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*